UFC heavyweight Walt Harris (11-7) has been suspended by the U.S. Anti-Doping Agency (USADA). The 35-year-old was flagged for LGD4033, which is in the same family as selective androgen receptor modules. The test was made before UFC 232 last December when “The Big Ticket” fought Andrei Arlovski.
Heavyweight Walt Harris Fails CSAC Drug Test at UFC 232 https://t.co/PEL4VPxu1k pic.twitter.com/YklpB32UIA
— Sherdog by Mandatory (@sherdogdotcom) January 23, 2019
Usually in similar cases the athletes are being banned from the sport for a period of 2 years, but Harris will be gone for 4 months because the fighter provided USADA with information about a dietary supplement product he was using before and at the time of the relevant sample collection.
Harris’s four-month period of ineligibility began on December 29, 2018, (day before UFC 232) the date his positive sample was collected. Under the rules, any decision concerning competition results is handled by the Commission and the UFC.
Harris defeated Arlovski but now the result was overturned by the CSAC to No Contest. The sanction will expire on April 29 which means the fighter will be able to participate in his upcoming fight against Sergey Spivak on May 4 in Canada.
